The SmPCs for other GLP-1 receptor agonists contain similar precautionary advice
As an obesity medicine physician scientist who regularly cares for patients with complex inflammatory conditions, this study reinforces what many of us have suspected clinically that the benefits of GLP-1 receptor agonists extend well beyond blood sugar control and weight loss and may fundamentally alter the disease trajectory for some of our highest-risk patients. Stanford, who was not involved in this research, is an obesity medicine physician scientist, educator and policy maker at Massachusetts General Hospital and Harvard Medical School, both in Boston
The mechanism of this interaction is complex since apoC-III itself does not bind artery wall proteoglycans, but seems to provoke changes in the lipid composition of the lipoproteins leading apoB to adopt a conformation that is more favorable for proteoglycan binding [23, 27]
While topical use is typically considered safe during pregnancy, many products marketed for "skin brightening" contain other ingredients like hydroquinone or high-strength retinoids, which are often advised against during pregnancy
A doctors guidance is crucial in determining which method of semaglutide administration will yield the best results
229 , 5867.e1 (2019)